Cytogenetics in multiple myeloma patients progressing into extramedullary disease-Reference-Cited by-同舟云学术

Cytogenetics in multiple myeloma patients progressing into extramedullary disease

Published:2015-10-19 Issue:1 Volume:97 Page:93-100
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Besse Lenka¹,Sedlarikova Lenka¹²,Greslikova Henrieta¹,Kupska Renata¹,Almasi Martina²,Penka Miroslav²,Jelinek Tomas³,Pour Ludek⁴,Adam Zdenek⁴,Kuglik Petr¹,Krejci Marta⁴,Hajek Roman¹²³,Sevcikova Sabina¹²

Affiliation:

1. Babak Myeloma Group; Department of Pathological Physiology; Faculty of Medicine; Masaryk University; Brno Czech Republic

2. Department of Clinical Hematology; University Hospital Brno; Brno Czech Republic

3. Department of Hematooncology; Faculty of Medicine; University Hospital Ostrava; University of Ostrava; Ostrava Czech Republic

4. Department of Internal Medicine - Hematooncology; University Hospital Brno; Brno Czech Republic

Funder

Czech Ministry of Health

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12688/fullpdf

Reference41 articles.

1. Multiple myeloma;Laubach;Annu Rev Med,2011

2. Extramedullary multiple myeloma;Weinstock;Leuk Lymphoma,2013

3. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach;Bladé;J Clin Oncol,2011

4. Extramedullary myeloma spread triggered by surgical procedures: an emerging entity?;Rosiñol;Acta Haematol,2014

5. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse;Pour;Haematologica,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease;Blood Cancer Journal;2024-08-26

2. Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients;Scientific Reports;2024-08-13

3. Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper;British Journal of Haematology;2024-07

4. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

5. Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors;Leukemia;2024-03-16